The last several weeks have been busy for SourceOne Healthcare Technologies. The company, which was formed in mid-January through the merger of imaging supply distributors Diagnostic Imaging and Healthcare Products, capped a deal with the military for 50
The last several weeks have been busy for SourceOne Healthcare Technologies. The company, which was formed in mid-January through the merger of imaging supply distributors Diagnostic Imaging and Healthcare Products, capped a deal with the military for 50 CR units, entered into two major alliances, and established a new headquarters. It announced Feb. 12 a $5 million contract with the Department of Defense to purchase more than 50 radiological systems manufactured by Orex Computerized Radiography. The Orex PcCR 1417 products include laser scanners and erasable phosphor plates. They will be positioned for use in battlefield situations.
On Feb. 4, SourceOne announced a three-year agreement with the group purchasing organization AmeriNet for equipment and supplies. The deal began Jan. 1 and could be worth $65 million annually, providing film, barium, service, and chemistry to some of AmeriNet's14,000-plus members.
On Jan. 30, the company announced a similar agreement, valued at up to $40 million annually, with MedAssets HSCA. MedAssets' members include more than 2200 acute care facilities and 9000 clinics.
The company also has new digs in Mentor, OH. The development package negotiated by Mentor city officials includes an annual grant, good for 10 years, based on the amount of payroll tax that SourceOne generates. The 170 employees will move to their new 42,000-square-foot structure in May. The SourceOne staff is expected to grow to 300 employees by year's end.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.